-3- (1H-INDOL-3-IL) -4- [2- (4-METHYL-PIPERAZIN-1-IL) -QUINAZOLIN-4-IL] -PIRROL-2,5-DIONA CRYSTAL MODIFICATIONS
- 专利权人:
- NOVARTIS AG
- 发明人:
- PIOTR KARPINSKI,STEPHANIE MONNIER,ELIAS NDZIE,DIMITRIS PAPOUTSAKIS,PAUL ALLEN SUTTON
- 申请号：
- BRPI0717461
- 公开号：
- BRPI0717461A2
- 申请日:
- 2007.10.18
- 申请国别(地区):
- BR
- 年份:
- 2013
- 代理人:
- 摘要：
- The invention relates to a new crystalline form of the acetate salt of which may be used, for example, for prevention or treatment of transplant rejection.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- צורה קריסטלית של–3–(1h–אינדול–3–יל)–4–[2–(4–מתיל–פיפראזין–1–יל)–קוינאזולין–4–יל]–פירול–2,5–דיאון אצטט, תכשיר רפואי המכיל אותה, תהליך להכנתה ושימושה בהכנת חומר פרמאקולוגי
- Crystalline form of 3- (1H-indol-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl] -pyrrole-2,5-dione
- Crystal modifications -3- (1H-indol-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl] -pyrrole-2, 5-dione
- COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING N-METHYLENENAPHTHO[2,1-b]FURAN-2-CARBOHYDRAZIDE DERIVATIVES AS AN ACTIVE INGREDIENT
- 신규한 메틸 2-(2-나프토일이미노-4-옥소티아졸리딘-5-일리딘)아세테이트 유도체 및 이의 항암 효과
